Synthesis of Novel 17-Oxo-17a-Aza-D-Homo-3, 5-Seco-Steroids as Potential 5α-Reductase Inhibitors
Authors
Abstract:
Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate gland. Itis a leading disorder of the elderly male population. Excessive production of dihydrotestosteronehas been implicated in this pathological condition. Steroidal 5α-reductase is a membrane boundNADPH dependent enzyme which is responsible for the conversion of testosterone (T) todihydrotestosterone (DHT). Therefore, inhibition of production of DHT by 5α-reductaseinhibitors is an important approach for the treatment of BPH. The proposed 17-oxo-17a-aza-Dhomo-3,5-seco-steroids (17-20) have been synthesized using diosgenin as the starting material.Diosgenin was converted to 17-oxo-3, 5-seco-4-nor-androstan-3-oic acid following six steps:Oppenauer oxidation, Lemieux-von Rudloff oxidation, Wolff-Kishner reduction, Markerdegradation, oximation and Beckmann rearrangement. 17-Oxo-3, 5- seco-keto acid was thenconverted to 17-oxo-17a-aza-D-homo-3, 5-seco-4-nor-androstan-3-oic acid by oximationfollowed by Beckmann rearrangement. The resulted seco-keto acid was then treated with thionylchloride and the respective amines and phenols to get the desired 3, 5-seco-steroidal amides (17-18) and esters (19-20) respectively.
similar resources
synthesis of novel 17-oxo-17a-aza-d-homo-3, 5-seco-steroids as potential 5α-reductase inhibitors
benign prostatic hyperplasia (bph) is a non-malignant enlargement of the prostate gland. itis a leading disorder of the elderly male population. excessive production of dihydrotestosteronehas been implicated in this pathological condition. steroidal 5α-reductase is a membrane boundnadph dependent enzyme which is responsible for the conversion of testosterone (t) todihydrotestosterone (dht). the...
full text5α-Reductase Inhibitors, antimicrobial and antioxidant activities of 3β- substituted amides of 17a-aza-D-homo-4-androsten-17-one
The study reports the convenient and efficient synthesis of several new analogues of 3β-substituted amides of 17a-aza-Dhomo-4-androsten-17-one (11a-11d) from commercially available Diosgenin as the starting material. The structures of newly synthesized compounds were confirmed by IR, H NMR, C NMR and mass spectrometry. We herein report the 5α-reductase inhibitory, antimicrobial and antioxidant ...
full textSynthesis and Characterization of 3β-substituted amides of 17a-aza-D- homo-4-androsten-17-one as 5α-Reductase Inhibitors, antimicrobial and antioxidant activities
The study reports the convenient and efficient synthesis of several new analogues of 3β-substituted amides of 17a-aza-Dhomo-4-androsten-17-one (3a-3e) from commercially available Diosgenin as the starting material. The structures of newly synthesized compounds were confirmed by IR, 1H NMR, 13C NMR and Mass spectrometry. We herein report the 5αreductase inhibitory, antimicrobial and antioxidant ...
full textSynthesis and biological evaluation of 5-arylfuro[2,3-d]pyrimidines as novel dihydrofolate reductase inhibitors.
A series of about fifty novel 5-arylfuro[2,3-d]pyrimidine derivatives were synthesized as potential inhibitors of dihydrofolate reductase (DHFR) arising from different species. Weak enzyme inhibition was observed for most of the compounds, with only a few reaching IC50 values less than 30 microM. With regards to antibacterial and anti-malarial potency, only seven compounds showed a modest in vi...
full textDesign, Synthesis and Biological Evaluation of 5-Oxo-1,4,5,6,7,8 Hexahydroquinoline Derivatives as Selective Cyclooxygenase-2 Inhibitors
A group of regioisomeric 5-oxo-1,4,5,6,7,8 hexahydroquinoline derivatives possessing a COX-2 SO2Me pharmacophore at the para position of the C-2 or C-4 phenyl ring, in conjunction with a C-4 or C-2 phenyl (4-H) or substituted-phenyl ring (4-F,4-Cl,4-Br,4-OMe,4-Me, 4-NO2), were designed for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. These target 5-oxo-1,4,5,6,7,8 hexahydroquino...
full textDesign, Synthesis and Biological Evaluation of 5-Oxo-1,4,5,6,7,8 Hexahydroquinoline Derivatives as Selective Cyclooxygenase-2 Inhibitors
A group of regioisomeric 5-oxo-1,4,5,6,7,8 hexahydroquinoline derivatives possessing a COX-2 SO2Me pharmacophore at the para position of the C-2 or C-4 phenyl ring, in conjunction with a C-4 or C-2 phenyl (4-H) or substituted-phenyl ring (4-F,4-Cl,4-Br,4-OMe,4-Me, 4-NO2), were designed for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. These target 5-oxo-1,4,5,6,7,8 hexahydroquino...
full textMy Resources
Journal title
volume 2 issue 3
pages 211- 219
publication date 2009-12-20
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023